König, C.; Both, A.; Rohde, H.; Kluge, S.; Frey, O.R.; Röhr, A.C.; Wichmann, D.
Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. Antibiotics 2021, 10, 649.
https://doi.org/10.3390/antibiotics10060649
AMA Style
König C, Both A, Rohde H, Kluge S, Frey OR, Röhr AC, Wichmann D.
Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. Antibiotics. 2021; 10(6):649.
https://doi.org/10.3390/antibiotics10060649
Chicago/Turabian Style
König, Christina, Anna Both, Holger Rohde, Stefan Kluge, Otto R. Frey, Anka C. Röhr, and Dominic Wichmann.
2021. "Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance" Antibiotics 10, no. 6: 649.
https://doi.org/10.3390/antibiotics10060649
APA Style
König, C., Both, A., Rohde, H., Kluge, S., Frey, O. R., Röhr, A. C., & Wichmann, D.
(2021). Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. Antibiotics, 10(6), 649.
https://doi.org/10.3390/antibiotics10060649